All Posts Tagged With: "hepatitis B virus"

Traditional Chinese medicine commands a unique position among all traditional medicines because of its 5000 years of history. Our own interest in natural products from traditional Chinese medicine was triggered in the 1990s, by artemisinin‐type sesquiterpene lactones from Artemisia annua L. As demonstrated in recent years, this class of compounds has activity against malaria, cancer cells, and schistosomiasis. Interestingly, the bioactivity of artemisinin and its semisynthetic derivative artesunate is even broader and includes the inhibition of certain viruses, such as human cytomegalovirus and other members of the Herpesviridae family (e.g., herpes simplex virus type 1 and Epstein‐Barr virus), hepatitis B virus, hepatitis C virus, and bovine viral diarrhea virus. Analysis of the complete profile of the pharmacological activities and molecular modes of action of artemisinin and artesunate and their performance in clinical trials will further elucidate the full antimicrobial potential of these versatile pharmacological tools from nature. Continued

Infectious agents have been implicated in the etiopathogenesis of various
vasculitides via numerous and overlapping mechanisms including direct microbial
invasion of endothelial cells, immune complex mediated vessel wall damage and
stimulation of autoreactive B and/or T cells through molecular mimicry and
superantigens. While the causative role of hepatitis B virus in polyarteritis
nodosa and hepatitis C virus in mixed cryoglobulinemia is clearly established,
evidence for the association of other infectious agents with vasculitis,
including human immunodeficiency virus, parvovirus B19, cytomegalovirus,
varicella zoster virus, Staphylococcus aureus, rickettsiaceae, Treponema
pallidum and Borrelia burgdorferi, among numerous others, is accumulating. The
spectrum of association of infectious agents; bacteria, viruses and parasites,
with systemic vasculitides, will be reviewed herewith. Continued